SCHEMBL29567059

SCHEMBL29567059

CSc1cc(-c2ccccc2C(C)C)nc(NS(=O)(=O)c2cnn(C)c2Cl)n1

nearest known ligand 0.34

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ USP1 O94782 3/20 0.31
▸ GAA P10253 2/20 0.31
▸ LMNA P02545 1/20 0.31
▸ FABP4 P15090 1/20 0.31
▸ FABP5 Q01469 1/20 0.31
▸ ALDH1A1 P00352 2/20 0.30
▸ NPSR1 Q6W5P4 2/20 0.30
▸ MAPT P10636 1/20 0.30
▸ RAB9A P51151 1/20 0.30
▸ TRPC5 Q9UL62 1/20 0.30
▸ KDM4E B2RXH2 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ HPGD P15428 1/20 0.30
▸ KMT2A Q03164 1/20 0.30
▸ TSHR P16473 1/20 0.30
▸ CCR4 P51679 1/20 0.30
▸ ACHE P22303 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309340 1.00 USP1 (0.31) USP1GAALMNAFABP4FABP5
SCHEMBL29566663 0.86 SCN1A (0.32) USP1GAALMNAFABP4FABP5
SCHEMBL24309702 0.86 SCN1A (0.32) USP1GAALMNAFABP4FABP5
SCHEMBL26808363 0.84 ALDH1A1 (0.35) USP1ALDH1A1MAPTTRPC5KDM4E
SCHEMBL26808359 0.84 GPR39 (0.35) USP1GAALMNAFABP4FABP5
SCHEMBL29566434 0.81 HTR1A (0.42) USP1ALDH1A1MAPTKDM4EKMT2A
SCHEMBL24309279 0.81 HTR1A (0.42) USP1ALDH1A1MAPTKDM4EKMT2A
SCHEMBL29566636 0.81 GAA (0.35) GAALMNAALDH1A1MEN1KMT2A
SCHEMBL26651236 0.81 GAA (0.35) GAALMNAALDH1A1MEN1KMT2A
SCHEMBL24309792 0.80 BRD4 (0.37) GAALMNANPSR1KDM4ECCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback